Close Menu

360Dx

New data shows that the test could eventually be useful in helping younger women avoid chemotherapy in the neoadjuvant setting.

More than 70 percent of labs surveyed experienced supply chain interruptions, forcing them to validate three or more diagnostic testing methods.